Hello. I am Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia. Welcome back to another installment of GI Common Concerns, in ...

A variety of lesions occur in the normal liver. This review will describe the most common benign, malignant, and infectious lesions. Illustration will be made of the magnetic resonance imaging (MRI) ...

Significantly more and smaller liver tumors can be detected by contrast-enhanced MRI when compared to whole-body FDG PET, say researchers from Massachusetts General Hospital in Boston. Significantly ...

WAYNE, N.J., July 8 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc., a leader in diagnostic imaging, announced today that the U.S. Food and Drug Administration (FDA) has approved EOVIST(R) ...

ENDRA Life Sciences NDRA recently announced positive findings from a clinical study assessing the measurement consistency of ...

Overview of secondary liver cancer care pathways, key treatment steps, and the situations where dendritic cell treatment may ...

A 72-year-old man with a history of chronic alcoholism and cirrhosis Child score A was referred to the oncology department of a tertiary hospital in Cali, Colombia, for assessment of a growing mass in ...

HCC develops in patients with underlying chronic liver disease or cirrhosis via a multistep process of carcinogenesis, ranging from a DN to early HCC and, finally, to overt HCC. All these precursors ...

Researchers from France have shown that hepatobiliary MR contrast agent uptake can predict survival in patients with resectable hepatocellular carcinoma (HCC) as well as 18 F-FDG PET/CT can. They ...

PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny minority of patients undergoing initial staging for hepatocellular carcinoma ...